Contents

Search


canagliflozin/metformin (Invokamet)

Indications: - diabetes mellitus type 2 Adverse effects: - see canagliflozin

Interactions

drug adverse effects of hypoglycemic agents

General

hypoglycemic combination

References

  1. FDA Safety Alert. 09/10/2015 Invokana and Invokamet (canagliflozin): Drug Safety Communication - New Information on Bone Fracture Risk and Decreased Bone Mineral Density. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm461876.htm

Components

canagliflozin (Invokana) metformin (Glucophage)